Denali Therapeutics (DNLI)
22.28
-0.52 (2.28%)
Upcoming Events
Latest Headlines
Denali Therapeutics Inc. (DNLI) PT Raised to $35 at B.Riley
August 25, 2026 8:29 AM - StreetInsider
Form 4 Denali Therapeutics Inc. For: Aug 12 Filed by: Watts Ryan J.
August 14, 2026 4:48 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Aug 11 Filed by: Schuth Alexander O.
August 13, 2026 5:02 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Schuth Alexander O.
August 11, 2026 5:40 PM - SEC Filing
Denali Therapeutics Inc. (DNLI) PT Raised to $34 at UBS
August 7, 2026 9:58 AM - StreetInsider
Denali Therapeutics Inc. (DNLI) Misses Q2 EPS by 4c
August 6, 2026 5:41 PM - StreetInsider
Form 10-Q Denali Therapeutics Inc. For: Jun 30
August 6, 2026 4:12 PM - SEC Filing
Form 8-K Denali Therapeutics Inc. For: Aug 06
August 6, 2026 4:04 PM - SEC Filing
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
August 6, 2026 4:01 PM - StreetInsider
Form SCHEDULE 13G/A Denali Therapeutics Inc. Filed by: BAILLIE GIFFORD & CO
August 4, 2026 9:11 AM - SEC Filing
Form 8-K Denali Therapeutics Inc. For: Jul 27
July 28, 2026 6:03 AM - SEC Filing
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
July 27, 2026 4:01 PM - StreetInsider
Denali Therapeutics Inc. (DNLI) PT Raised to $36 at Morgan Stanley
July 23, 2026 8:43 AM - StreetInsider
Denali Therapeutics Inc. (DNLI) PT Raised to $35 at Deutsche Bank
July 17, 2026 7:17 AM - StreetInsider
Denali Therapeutics (DNLI) call put ratio 1.3 calls to 1 put as share price up 2.2%
July 13, 2026 2:20 PM - StreetInsider
JPMorgan Resumes Denali Therapeutics Inc. (DNLI) at Overweight
July 13, 2026 3:14 AM - StreetInsider
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba
July 9, 2026 4:01 PM - StreetInsider
Form SCHEDULE 13G/A Denali Therapeutics Inc. Filed by: T. Rowe Price Investment Management, Inc.
July 8, 2026 11:30 AM - SEC Filing
June 22, 2026 9:26 AM - StreetInsider
Stifel Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
June 22, 2026 9:26 AM - StreetInsider
Form 8-K Denali Therapeutics Inc. For: Jun 12
June 18, 2026 8:02 AM - SEC Filing
Denali Therapeutics to sell priority review voucher for $195M
June 18, 2026 8:00 AM - StreetInsider
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
June 18, 2026 8:00 AM - StreetInsider
UBS Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
June 16, 2026 9:27 AM - StreetInsider
Full Article List
